Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: Role for peripheral TNFα, IL-1β and IL-10
Autor: | Thiago M. Cunha, Waldiceu A. Verri, Rubia Casagrande, Felipe A. Pinho-Ribeiro, Sandra S. Mizokami, Thacyana T. Carvalho, Sergio M. Borghi, Sergio H. Ferreira, Fernando Q. Cunha |
---|---|
Rok vydání: | 2015 |
Předmět: |
medicine.drug_class
medicine.medical_treatment Interleukin-1beta Pain G-CSF Pharmacology Receptors Tumor Necrosis Factor LEUCÓCITOS Etanercept Pentoxifylline Leukocyte Count Granulocyte Colony-Stimulating Factor medicine Animals Cytokine Skin Mice Knockout Morphine Tumor Necrosis Factor-alpha business.industry Interleukin Receptor antagonist Interleukin-10 Thalidomide Analgesics Opioid Mice Inbred C57BL Interleukin 1 Receptor Antagonist Protein Interleukin 10 Hyperalgesia Receptors Tumor Necrosis Factor Type I Immunoglobulin G Immunology Tumor necrosis factor alpha medicine.symptom business medicine.drug |
Zdroj: | Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP |
ISSN: | 0014-2999 |
DOI: | 10.1016/j.ejphar.2014.12.023 |
Popis: | Granulocyte-colony stimulating factor (G-CSF) is a therapeutic approach to increase peripheral neutrophil counts after anti-tumor therapies. Pain is the major side effect of G-CSF. Intraplantar administration of G-CSF in mice induces mechanical hyperalgesia. However, the peripheral mechanisms involved in this effect were not elucidated. Therefore, the participation of pronociceptive cytokines tumor necrosis factor (TNF) alpha (TNFα), interleukin (IL)-1 beta (IL-1β) and antinociceptive cytokine IL-10 in G-CSF-induced mechanical hyperalgesia in mice was investigated. G-CSF-induced mechanical hyperalgesia was inhibited by systemic and local treatment with etanercept and IL-1 receptor antagonist (IL-1ra) or TNF receptor 1 (TNFR1) deficiency and increased in IL-10 deficient mice. In agreement, G-CSF injection induced significant TNFα, IL-1β and IL-10 production in paw tissue. G-CSF-induced hyperalgesia was dose-dependently inhibited by thalidomide (5–45mg/kg) and pentoxifylline (0.5–13.5mg/kg), and treatment with these drugs inhibited G-CSF-induced TNFα, IL-1β and IL-10 production. The combined treatment with pentoxifylline or thalidomide with morphine, at doses that are ineffective as single treatment, diminished G-CSF-induced hyperalgesia through inhibiting cytokine production. Indomethacin also reduces G-CSF hyperalgesia alone or combined with pentoxifylline or thalidomide. Thus, G-CSF-induced hyperalgesia might be mediate by peripheral production of pronociceptive cytokines TNFα and IL-1β and down-regulated by IL-10. Systemic IL-1ra reduced G-CSF-induced increase of peripheral neutrophil counts. However, local treatment with morphine, IL-1ra or etanercept, and systemic treatment with indomethacin, etanercept, thalidomide and pentoxifylline did not alter G-CSF-induced mobilization of neutrophils. Therefore, this study advances in the understanding of G-CSF-induced hyperalgesia and suggests therapeutic approaches for its control. |
Databáze: | OpenAIRE |
Externí odkaz: |